3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Cognition Disorders in 1 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carli, M | 1 |
| Calcagno, E | 1 |
| Mainolfi, P | 1 |
| Mainini, E | 1 |
| Invernizzi, RW | 1 |
1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Cognition Disorders
| Article | Year |
|---|---|
Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines | 2011 |